| 英文摘要 |
Taiwan CDC supervises quality management of the National Laboratory System conducting diagnostic testing of major infectious diseases, which includes 1 appointed lab, 16 commissioned labs, 270 authorized labs, and 1 pathological anatomy lab. All of the indicators, including laboratory testing for detection of 10 priority diseases, specimen referral and transport system, effective modern point of care and llaboratory-based diagnostics, as well as laboratory quality system, were verified to have sustainable capacity and thus reached to the full-score level. In 2017, the CDC national laboratories tested 118,923 specimens, and were accredited by TAF according to the ISO15189 on December 26. 1. In 2017, 48 H1N1pdm09, 311 H3N2 and 183 influenza B viruses were antigenically characterized. Of them, 31 (10%) H3N2 and 8 (4.4%) influenza B viruses reacted poorly with ferret antisera of vaccine strains. Influenza A(H3N2) viruses were found to have an increased viral genetic heterogeneity. 2. In 2017, 48 A(H1N1)pdm09, 247 H3N2 and 224 influenza B viruses were tested for oseltamivir resistance. Two resistant influenza B viruses were detected. 3. One human infection caused by an avian influenza A (H7N9) virus with a polybasic cleavage site was identified in 2017. |
本站僅提供期刊文獻檢索。
